Novavax transfers EU rights for Nuvaxovid to Sanofi, earning milestone payments and future royalties. Read more here.

Novavax, Inc. (Nasdaq: NVAX) has completed the transfer of the marketing authorization for its COVID-19 vaccine, Nuvaxovid® ...

Novavax Inc on Monday pushed back the start of a U.S.-based, late-stage trial for its experimental COVID-19 vaccine for the second time and now expects it to begin in the coming weeks instead of ...

Novavax Inc on Tuesday delayed the start of a late-stage U.S. trial of its experimental coronavirus vaccine by roughly a month to the end of November, citing delays in scaling up the manufacturing ...

Novavax (NVAX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Sanofi recently announced an expansion of its licensing agreement with Novavax, granting it broader rights to use Novavax's Matrix-M adjuvant in Sanofi's pandemic influenza vaccine candidate program ...

Novavax ( ($NVAX) ) has issued an update. On October 1, 2025, the European Commission approved the transfer of the marketing authorization for ...

Novavax, Inc. (Nasdaq: NVAX) today announced progress on its collaboration and license agreement (CLA) with Sanofi regarding ...

Amid confusion over this year's updated COVID-19 vaccines, we explain what's different this year and who experts say should ...

GoodRx reports that CDC now recommends COVID-19 vaccinations be decided with healthcare professionals, stressing personalized ...

Trump's physician, Sean Barbabella, shared news of the president's COVID vaccination in a letter to White House press secretary Karoline Leavitt.

The Centers for Disease Control and Prevention on Monday officially recommended updated coronavirus vaccines, creating a new ...